The Oncology Institute, Inc.
The Oncology Institute, Inc. (TOI) Revenue
Annual & quarterly revenue history · segment & region breakdown
TOI · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsThe Oncology Institute, Inc. trailing twelve-month (TTM) revenue is $0.55B, an increase of 27.79% year-over-year from $0.50B in FY2025.
Revenue trend
2025 – 2018 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.50B | +$0.11B | +27.79% |
| 2024-12-31 | $0.39B | +$0.07B | +21.33% |
| 2023-12-31 | $0.32B | +$0.07B | +28.42% |
| 2022-12-31 | $0.25B | +$0.05B | +24.37% |
| 2021-12-31 | $0.20B | +$0.02B | +8.26% |
| 2020-12-31 | $0.19B | +$0.03B | +20.66% |
| 2019-12-31 | $0.16B | +$0.04B | +37.33% |
| 2018-12-31 | $0.11B | — | — |
Compare revenue vs peers
Medical - Care FacilitiesCompare TOI revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income The Oncology Institute, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
The Oncology Institute, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from The Oncology Institute, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
TOI revenue · 4 questionsTOI's trailing twelve-month (TTM) revenue is $0.55B. That is an increase of 27.79% year-over-year from $0.50B in FY2025.
▸ Source: FMP · The Oncology Institute, Inc. SEC filings · GAAP · The Oncology Institute, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026